Efficacy and safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in diabetic nephropathy: a systematic review and meta-analysis.

Du, Yuan-Hong; Guan, Cheng-Jing; Li, Lin-Yu; Gan, Ping

Du, Yuan-Hong; Guan, Cheng-Jing; Li, Lin-Yu; Gan, Ping.

Afiliação

Du YH; Department of Nephrology, Guizhou Medical University, Guiyang, China.
Guan CJ; Department of Nephrology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Li LY; Department of Nephrology, Ziyang Hospital of Traditional Chinese Medicine, Ziyang, China.
Gan P; Department of Nephrology, Guizhou Medical University, Guiyang, China; Department of Nephrology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.

Ann Palliat Med ; 11(3): 1093-1101, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35365039

Assuntos

Diabetes Mellitus; Nefropatias Diabéticas; Antagonistas de Receptores de Angiotensina/efeitos adversos; Inibidores da Enzima Conversora de Angiotensina/efeitos adversos; Creatinina; Diabetes Mellitus/tratamento farmacológico; Nefropatias Diabéticas/induzido quimicamente; Nefropatias Diabéticas/tratamento farmacológico; Humanos; Qualidade de Vida

Palavras-chave

Angiotensin-converting enzyme inhibitors (ACEIs); angiotensin II receptor blockers (ARBs); diabetic nephropathy (DN); meta-analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus / Nefropatias Diabéticas Tipo de estudo: Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google